Response to Mishra et al . re “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2”

Abdool Karim SS , and de Oliveira T . New SARS-CoV-2 variants—clinical, public health, and vaccine implications. N Engl J Med, 2021; 384:1866–1868.

Crotty S . Hybrid immunity. Science, 2021; 372:1392–1393.

Krsak M , Harry BL , Palmer BE , and Franco-Paredes C . Postinfectious immunity after COVID-19 and vaccination against SARS-CoV-2. Viral Immunol, 2021; 34:504–509.

Mishra BK , Bhattacharya D , Kshatri JS , and Pati S . Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al . Viral immunol, 2021; 34:658–659.

Painter MM , Mathew D , Goel RR , et al. Rapid induction of antigen-specific CD4⁺ T cells is associated with coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination. Immunity, 2021; 54:2133–2142.e3.

Tan CW , Chia WN , Young BE , et al. Pan-sarbecovirus neutralizing antibodies in BNT162b2-immunized SARS-CoV-1 survivors. N Engl J Med, 2021; 385:1401–1406.

Tarke A , Sidney J , Methot N , et al. Impact of SARS-CoV-2 variants on the total CD4⁺ and CD8⁺ T cell reactivity in infected or vaccinated individuals. Cell Rep Med, 2021; 2:100355.

Wang Z , Lorenzi JCC , Muecksch F , et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med, 2021; 13:eabf1555.

Woldemeskel BA , Garliss CC , and Blankson JN . SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63. J Clin Invest, 2021; 131:e149335.

Wu K , Choi A , Koch M , et al.. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. bioRxiv [Preprint] 2021:2021.04.13.439482. [Epub ahead of print]; DOI: 10.1101/2021.04.13.439482.